These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12170749)

  • 21. [Long-term results of short course chemotherapy of pulmonary tuberculosis. Second study-B: results at 6 years after the end of 4-9 month chemotherapy of pulmonary tuberculosis].
    Baba H; Shinkai A; Izuchi R; Azuma Y
    Kekkaku; 1987 Oct; 62(10):511-20. PubMed ID: 3444194
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical results obtained with Isoprodian in the treatment of new cases of pulmonary tuberculosis.
    Sighart H
    Scand J Respir Dis Suppl; 1978; 102():60-1. PubMed ID: 356259
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to short-course chemotherapy of patients with initial resistance to antituberculosis drugs.
    Valenzuela P; Valenzuela MT; Ponce J
    Bull Pan Am Health Organ; 1988; 22(2):175-83. PubMed ID: 3048504
    [No Abstract]   [Full Text] [Related]  

  • 25. [New guidelines for pulmonary tuberculosis therapy].
    Steiner A; Medici TC
    Dtsch Med Wochenschr; 1978 Mar; 103(9):372-5. PubMed ID: 631063
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of British Thoracic Society and American Thoracic Society reintroduction guidelines for anti-tuberculous therapy induced liver injury.
    Zuberi BF; Zuberi FF; Bader N; Alvi H; Salahuddin J
    J Pak Med Assoc; 2014 Aug; 64(8):896-9. PubMed ID: 25252514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent tuberculosis: definitions and treatment regimens.
    Harries AD; Hargreaves NJ; Kwanjana JH; Salaniponi FM
    Int J Tuberc Lung Dis; 1999 Oct; 3(10):851-4. PubMed ID: 10524580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Report on the recommendations of the American Thoracic Society regarding treatment of patients with tuberculosis or tuberculosis-infected adults and children].
    Neumann G
    Prax Klin Pneumol; 1987 Mar; 41(3):95. PubMed ID: 3588534
    [No Abstract]   [Full Text] [Related]  

  • 30. ATS adopts diagnostic standards for tuberculosis. American Thoracic Society.
    Am Fam Physician; 2001 Mar; 63(5):979-80. PubMed ID: 11261870
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of tuberculosis].
    Dautzenberg B
    Rev Prat; 1996 Jun; 46(11):1350-5. PubMed ID: 8794618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivation of tuberculosis after apparently adequate chemoprophylaxis.
    Currie GP; Emmanuel FX; Ford D; Devereux G
    J Infect; 2005 Dec; 51(5):e305-8. PubMed ID: 16321645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of isofon in combined treatment of patients with acutely progressive forms of tuberculosis].
    Chelnokova OG; Kibrik BS
    Probl Tuberk Bolezn Legk; 2003; (9):12-4. PubMed ID: 14598518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Short-course chemotherapy of pulmonary tuberculosis and several problems concerning its use, especially in India].
    Fox W
    Bull Int Union Tuberc; 1985; 60(1-2):44-54. PubMed ID: 3935193
    [No Abstract]   [Full Text] [Related]  

  • 37. [Causes and factors of development of drug resistance in pulmonary tuberculosis].
    Nechaeva OB; Skachkova EI
    Probl Tuberk Bolezn Legk; 2003; (9):6-9. PubMed ID: 14598516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Clin Chest Med; 1980 May; 1(2):243-52. PubMed ID: 6794977
    [No Abstract]   [Full Text] [Related]  

  • 39. Which regimen to be used in retreatment cases of pulmonary tuberculosis?
    Agarwal SK; Sundar S
    J Assoc Physicians India; 1986 Mar; 34(3):227. PubMed ID: 3733660
    [No Abstract]   [Full Text] [Related]  

  • 40. [Miss-management in treatment failure of pulmonary tuberculosis].
    Ito K; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2004 Oct; 79(10):561-7. PubMed ID: 15631107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.